of non-pandemic deaths globally were caused by noncommunicable diseases in WHO's 2021 estimates.
WHO · Noncommunicable diseases ↗About BioMIR
Scientific rationale.
Longitudinal scope.
BioMIR is a privacy-first analytical platform for longitudinal interpretation of behavioral, recovery-related, cardiometabolic, and clinical observations. It converts heterogeneous measurements into traceable age-referenced model outputs while preserving domain attribution, measurement provenance, observation recency, and data-quality context. The outputs are analytical estimates—not diagnoses, treatment recommendations, or direct measurements of lifespan.
Scientific premise
Prevention is longitudinal; measurement is usually intermittent.
Noncommunicable diseases account for a large share of global mortality and disability, and many major cardiometabolic risks are influenced by modifiable exposures. Prevention research therefore includes identifying risk and protective factors and recognizing early-stage change before progression becomes clinically established.
The analytical problem is temporal: behavior can change within hours, wearable physiology over hours to days, cardiometabolic measurements more intermittently, and laboratory panels episodically. BioMIR is designed to preserve those differences rather than collapse every observation into an undifferentiated health score.
U.S. adults have at least one chronic condition; more than half have two or more.
CDC · Chronic diseases in America ↗of U.S. annual health expenditures are for people with chronic and mental health conditions.
CDC · Health and economic costs ↗Prevention framework: NIH Office of Disease Prevention · What is Prevention Research? ↗
Analytical objective
Make longitudinal change measurable and auditable.
BioMIR organizes longitudinal observations into a transparent analytical sequence: Behavioral Adaptation → Recovery → Cardiometabolic Anchors → Clinical Clocks. Adaptive BioAge synthesizes the first three daily layers; KDM and clinical PhenoAge remain separate periodic laboratory models.
The objective is not to infer causation from temporal order. It is to make a modeled change traceable to the contributing measurement, source date, directionality, reference context, and data-quality metadata so that persistent signal can be distinguished from transient variation and incomplete evidence.
Scientific design principles
Model specification is distinct from validation.
Published biomarker associations and established biological-age methods can support model design without validating a particular software implementation, coefficient set, composite, or target population. BioMIR therefore separates method provenance, implementation choices, data quality, and empirical validation.
A precise-looking estimate remains a model output whose interpretation depends on its measurements, assumptions, and evidence.
Preserve biological timescale
Keep proximal exposures, intermediate physiological response, slower cardiometabolic state, and episodic clinical phenotype analytically distinct.
Preserve provenance and uncertainty
Keep source, observation date, contributor structure, Completeness, and CMA Freshness visible rather than presenting every value as equally current or certain.
Require validation beyond plausibility
Evaluate calibration, longitudinal reliability, measurement error, missingness, subgroup transportability, reproducibility, and clinically meaningful outcomes separately from component-level evidence.
Founder
Analytical Science
Applied Upstream
BioMIR was created by Yonathan Emmanuel, a biomedical and analytical scientist with more than two decades in healthcare, spanning clinical diagnostics and analytical development for protein therapeutics. That background emphasizes measurement validity, signal-to-noise discrimination, longitudinal process control, traceability, and explicit handling of analytical variability.
BioMIR applies those measurement-science principles to longitudinal health data: repeated observations are interpreted in relation to population context, biological timescale, provenance, and within-person trajectory. The analogy is methodological rather than regulatory—principles used to characterize biological change can inform preventive analytics, but BioMIR requires its own validation and is not represented as a therapeutic-development assay or diagnostic test.
Professional background, scientific collaboration, or inquiries:
Scientific documentation
Inspect the model.
Trace the evidence.
Review the public methods specification, interpretation boundaries, and supporting literature.